ReutersNovartis gene therapy approval signals new cancer treatment eraReuters(Reuters) – Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment… Continue reading
ReutersNovartis gene therapy approval signals new cancer treatment eraReuters(Reuters) – Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment… Continue reading
New AtlasVideo gamers tasked with helping develop new molecule for controlling CRISPRNew AtlasEarlier in 2016 Eterna players were tasked with designing a novel molecule to assist with the creation of a simple and accurate blood test for tuberculosis. … Continue reading
Conventional and novel stem cell based therapies for androgenic alopeciaDove Medical PressBiologic factors that include signaling from stem cells, dermal papilla cells, and platelet-rich plasma are some of the current therapeutic agents being studied f… Continue reading
Market News Call |
Novartis $475000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool Novartis’ Kymriah and Kite Pharma’s (soon to be Gilead Sciences’) CAR-Ts work similarly. Each involves removing a patient’s T–cells and shipping them to a facility where they’re engineered to spot and bind to CD19, a protein commonly expressed by B … Gilead Sciences’ Purchase Deal With Kite Pharma: Potential Scenarios And Associated ActionsSeeking Alpha |
Market News Call |
Novartis $475000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool Novartis’ Kymriah and Kite Pharma’s (soon to be Gilead Sciences’) CAR-Ts work similarly. Each involves removing a patient’s T–cells and shipping them to a facility where they’re engineered to spot and bind to CD19, a protein commonly expressed by B … Gilead Sciences’ Purchase Deal With Kite Pharma: Potential Scenarios And Associated ActionsSeeking Alpha |
|
Ground-Breaking Immunotherapy for Childhood Leukemia Gets FDA OK
Health Essentials from Cleveland Clinic (blog) It is a type of immunotherapy, a one-time infusion that uses the body’s own defenses to attack the cancer. It’s approved for use in certain children and young adults up to age 25, who are fighting a form of acute lymphoblastic leukemia (ALL). ALL is a … |
Business Insider |
A startup raised $127 million to treat genetic diseases without using CRISPR
Business Insider The gene-editing system CRISPR is the hottest subject in biology because of the technique’s ability to change DNA letters and potentially cure genetic disease. So what could be better? What about a way to edit genes with no CRISPR at all. A startup … |